BALTIMORE, Oct. 27 /PRNewswire/ — Paragon Bioservices, a
Baltimore-based CMO focused on the contract research, process
development and manufacturing of biologics, announced today that
the company will celebrate its 20th anniversary in November by
undergoing a second expansion of facilities at the University of
Maryland Biopark in Baltimore, MD. The expansion will double
existing GMP manufacturing capacity, include additional research
and process development laboratories and add fill and finish
capabilities. Completion is scheduled for the second quarter
of 2011.
When completed, the “New Paragon,” approximately a 45,000 square
foot facility, will be the only multiple project GMP contract
manufacturing organization (CMO) in the Baltimore-Metropolitan area
and only one of a few in the Mid-Atlantic region.
Marco Chacon, Ph.D., CEO of Paragon Bioservices, commented, “As
the demand for the development of biopharmaceuticals continues to
increase, Paragon is meeting our customer demands with expansions
to our facilities, staff and equipment. This enhances our
ability to produce recombinant proteins, both for research purposes
and for Phase I and II clinical trials.”
About Paragon BioservicesParagon Bioservices is a contract
research and manufacturing organization (CMO) that provides a
comprehensive portfolio of services — including process
development, GMP manufacturing and cell banking. Paragon’s focus is
to bridge the translational divide, to enable protein and
cell-based therapeutics into clinical trials. Our experienced
process engineers, regulatory compliance associates and project
managers work with our clients — from start to finish. For
more information about Paragon Bioservices, please visit www.paragonbioservices.com.Media
Contacts:Tiberend Strategic Advisors, Inc.(212) 827-0020 Tamara
Bright
tbright@tiberend
‘/>”/>
